Connor, Clark & Lunn Investment Management (CC&L)’s Ventyx Biosciences VTYX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
945,206
+73,601
| +8% | +$158K | 0.01% | 860 |
|
|
2025
Q1 | $1M | Buy |
871,605
+78
| +0% | +$90 | ﹤0.01% | 950 |
|
|
2024
Q4 | $1.91M | Buy |
871,527
+409,357
| +89% | +$896K | 0.01% | 738 |
|
|
2024
Q3 | $1.01M | Buy |
462,170
+42,600
| +10% | +$92.9K | ﹤0.01% | 885 |
|
|
2024
Q2 | $969K | Sell |
419,570
-56,049
| -12% | -$129K | ﹤0.01% | 850 |
|
|
2024
Q1 | $2.62M | Buy |
475,619
+244,967
| +106% | +$1.35M | 0.01% | 604 |
|
|
2023
Q4 | $570K | Buy |
230,652
+166,708
| +261% | +$412K | ﹤0.01% | 1012 |
|
|
2023
Q3 | $2.22M | Buy |
63,944
+37,240
| +139% | +$1.29M | 0.01% | 591 |
|
|
2023
Q2 | $876K | Buy |
+26,704
| New | +$876K | ﹤0.01% | 833 |
|